Valeant Pharmaceuticals International Inc Shares Slide 13.2% Below Kornwasser's Purchase Price

There's an old saying on Wall Street about insider buying: there are many possible reasons to sell a stock, but only one reason to buy. Back on March 21, Valeant Pharmaceuticals International Inc's EVP, Company Group Chairman, Laizer Kornwasser, invested $334,859.33 into 2,481 shares of VRX, for a cost per share of $134.97..